Abstract
BackgroundUsing a proteomics approach we have recently identified a novel blood-based biomarker for heart failure called CLEC3B, which exhibits improved diagnostic accuracy over BNP. We have previously investigated CLEC3B expression...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
